RECURSION PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • March 22nd, 2021 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMarch 22nd, 2021 Company Industry JurisdictionThis Indemnification Agreement (this “Agreement”) is dated as of [insert date], and is between Recursion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and [insert name of indemnitee] (“Indemnitee”).
CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • March 22nd, 2021 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 22nd, 2021 Company Industry JurisdictionTHIS CREDIT AND SECURITY AGREEMENT (this “Agreement”), dated as of September 18, 2019 (the “Closing Date”) by and among MIDCAP FINANCIAL TRUST, a Delaware statutory trust (“MidCap”), as administrative agent, the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a “Lender”, and collectively the “Lenders”), and RECURSION PHARMACEUTICALS, INC., a Delaware corporation as Borrower (“Borrower”), provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay the Lenders. The parties agree as follows:
OFFICE LEASE VESTAR GATEWAY, LLC, a Delaware limited liability company, as Landlord, and RECURSION PHARMACEUTICALS, INC., a Delaware corporation, as Tenant.Office Lease • March 22nd, 2021 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Utah
Contract Type FiledMarch 22nd, 2021 Company Industry JurisdictionThis Office Lease (the “Lease”), dated as of the date set forth in Section 1 of the Summary of Basic Lease Information (the “Summary”), below, is made by and between VESTAR GATEWAY, LLC, a Delaware limited liability company (“Landlord”), and RECURSION PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
March 21, 2021 Christopher Gibson c/o Recursion Pharmaceuticals, Inc. Salt Lake City, UT 84101 Re: Confirmatory Employment Letter Dear Chris:Letter Agreement • March 22nd, 2021 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Utah
Contract Type FiledMarch 22nd, 2021 Company Industry JurisdictionThis letter agreement (the “Agreement”) is entered into between the undersigned (“you”) and Recursion Pharmaceuticals, Inc. (the “Company” or “we”). This Agreement is effective as of the date you sign it, as indicated below. The purpose of this Agreement is to confirm the current terms and conditions of your employment.
CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS NOT MATERIAL AND (I) WOULD BE COMPETITIVELY HARMFUL TO THE REGISTRANT IF PUBLICLY DISCLOSED OR (II) IS INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL....License Agreement • March 22nd, 2021 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 22nd, 2021 Company Industry JurisdictionThis Research Collaboration and Option Agreement (this “Agreement”), dated as of August 28th, 2020 (the “Effective Date”), is made by and between Recursion Pharmaceuticals, Inc., a Delaware corporation with offices at 41 S Rio Grande Street, Salt Lake City, UT 84101 (“Recursion”) and Bayer AG, a German corporation, with offices at 42096 Wuppertal, Germany (“Bayer”). Each of Recursion and Bayer may be referred to herein as a “Party” or together as the “Parties”.
AMENDED AND RESTATED LEASE BY AND BETWEEN BERRUETA FAMILY L.P., LESSOR AND MOUSERA, INC., LESSEE Milpitas, California July 27, 2015Lease • March 22nd, 2021 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 22nd, 2021 Company Industry JurisdictionTHIS AMENDED AND RESTATED LEASE, referred to herein as this “Lease,” is made and entered into as of July 27, 2015, by and between BERRUETA FAMILY L.P., a California limited partnership, hereafter referred to as “Lessor,” and MOUSERA, INC., a Delaware corporation, hereafter referred to as “Lessee” or “Mousera”.
LEASE AGREEMENT By and Between: INDUSTRY OFFICE SLC, LLC a Delaware limited liability company LANDLORD and RECURSION PHARMACEUTICALS, INC., a Delaware corporation TENANT 650 South 500 West Salt Lake City, UT 84101Office Lease • March 22nd, 2021 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Utah
Contract Type FiledMarch 22nd, 2021 Company Industry JurisdictionTHIS INDUSTRY COMMERCIAL BUILDING OFFICE LEASE (this “Lease”) is dated as of the Effective Date, by and between Landlord and Tenant. Landlord and Tenant for themselves and their successors and assigns, hereby agree as follows:
March 21, 2021 Michael Secora c/o Recursion Pharmaceuticals, Inc. Salt Lake City, UT 84101 Re: Confirmatory Employment Letter Dear Michael:Letter Agreement • March 22nd, 2021 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Utah
Contract Type FiledMarch 22nd, 2021 Company Industry JurisdictionThis letter agreement (the “Agreement”) is entered into between the undersigned (“you”) and Recursion Pharmaceuticals, Inc. (the “Company” or “we”). This Agreement is effective as of the date you sign it, as indicated below. The purpose of this Agreement is to confirm the current terms and conditions of your employment.